PTC Therapeutics, Inc.
NASDAQ:PTCT
Overview | Financials
Company Name | PTC Therapeutics, Inc. |
Symbol | PTCT |
Currency | USD |
Price | 41.81 |
Market Cap | 3,224,600,431 |
Dividend Yield | 0% |
52-week-range | 23.58 - 54.16 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Matthew B. Klein F.A.C.S., FACS, M.D., M.S., MS |
Website | https://www.ptcbio.com |
An error occurred while fetching data.
About PTC Therapeutics, Inc.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD